Gilder Gagnon Howe & Co Llc
Source: SEC Form 13F · as of Mar 2026Gilder Gagnon Howe & Co Llc holds 24 biotech & pharma companies tracked by BioSniper, totaling $389.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$389.7M
| Company | Shares | Value |
|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | 4,304,010 | $101.4M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 280,092 | $92.7M |
| ALHCAlignment Healthcare Inc. | 1,833,691 | $32.3M |
| BBIOBridgeBio Pharma, Inc. | 420,325 | $31.2M |
| CYTKCYTOKINETICS INC | 330,989 | $21.8M |
| KYMRKymera Therapeutics, Inc. | 235,433 | $19.6M |
| NKTRNEKTAR THERAPEUTICS | 271,758 | $19.6M |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 29,391 | $15.4M |
| OSCROscar Health Inc. | 1,074,592 | $12.3M |
| KRYSKrystal Biotech, Inc. | 40,128 | $10.4M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 241,475 | $7.7M |
| CTMXCytomX Therapeutics, Inc. | 1,120,309 | $5.3M |
| IMNMImmunome Inc. | 169,267 | $3.7M |
| STOKStoke Therapeutics, Inc. | 112,627 | $3.7M |
| TLSITriSalus Life Sciences Inc. | 888,515 | $3.6M |
| COGTCogent Biosciences, Inc. | 52,163 | $2.0M |
| ARGXARGENX SE | 2,384 | $1.7M |
| PHATPhathom Pharmaceuticals, Inc. | 139,889 | $1.6M |
| PCVXVaxcyte, Inc. | 17,175 | $998K |
| ERASErasca, Inc. | 56,597 | $916K |
| BIIBBIOGEN INC. | 4,558 | $836K |
| MAZEMaze Therapeutics, Inc. | 17,487 | $522K |
| ADPTAdaptive Biotechnologies Corp | 22,719 | $315K |
| SANASana Biotechnology, Inc. | 95,796 | $276K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.